Advent International agreed to acquire a majority interest in Bharat Serums and Vaccines, provider of biopharmaceutical healthcare, assisted reproductive treatment, critical care and emergency medicine in India and emerging markets. Financial terms were not disclosed. With this transaction, OrbiMed PE and Kotak PE, two private equity firms that previously held minority positions in Bharat Serums, will fully exit their investments in the company. The Daftary family, which founded BSV, is retaining a meaningful equity stake in the business and is partnering with Advent on the company’s next stage of growth. "Bharat Serums has a differentiated portfolio of biotech and biological offerings in high-growth segments. We are also excited about the company’s robust R&D pipeline, which offers the potential to capture whitespace both in India and global markets," Pankaj Patwari, Advent International Director.